Clinical investigation shows safety of static magnetic field in participants receiving antineoplastic chemotherapy, suggesting potential for reduced toxicity.
A Static Magnetic Field in the form of a permanent magnet was applied to participants in an investigational protocol to determine the toxicity and safety profile of the magnetic field in participants receiving antineoplastic chemotherapy for advanced cancer. The magnet was placed 15 minutes prior to starting the antineoplastic chemotherapy and then remained in place for three levels following completion of the therapy for 0, 15, and 30 minutes. The data showed that overall, the presence of a static magnetic field could be applied safely to individuals receiving antineoplastic chemotherapy for advanced cancer, and for participants in the Level 3 Group (magnet applied for 30 minutes), there was a statistically significant decrease in toxicity compared to matched controls. We were not able to determine if the static magnet field had an effect on survival. Our data suggests that applying a static magnetic field to individuals receiving antineoplastic chemotherapy for advanced cancer is safe and may, under certain parameters, decrease the toxicity of the therapy. Further studies should be conducted.
No takes yet. Share an insight, caveat, or question.
Bailey et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: